Baseline anti‐CMV cellular immunity is similar between patients with a kidney transplant or receiving hemodialysis.

Autor: Noble, Johan, Maniere, Louis, Pernollet, Martine, Jacob, Marie‐Christine, Germi, Raphaëlle, Chevallier, Eloi, Rostaing, Lionel
Předmět:
Zdroj: Transplant International; Aug2020, Vol. 33 Issue 8, p961-962, 2p
Abstrakt: Baseline anti-CMV cellular immunity is similar between patients with a kidney transplant or receiving hemodialysis Anti-CMV cellular immunity may be assessed using Quantiferon-CMV (QF-CMV), which quantifies interferon gamma (IFN- ) production by CD8 SP + sp T cells following CMV antigen stimulation. However, no study has compared baseline QF-CMV anti-CMV cellular immunity between kidney transplant patients and hemodialysis patients who are kidney transplant candidates and compared these data with those from healthy volunteers. [Extracted from the article]
Databáze: Complementary Index